Location History:
- Zur Yigal, IL (2006 - 2008)
- Kokhav Ya'ir-Tzur Yigal, IL (2015 - 2017)
Company Filing History:
Years Active: 2006-2017
Title: Rakefet Cohen: Innovator in Pharmaceutical Preparation
Introduction
Rakefet Cohen, an accomplished inventor based in Kokhav Ya'ir-Tzur Yigal, Israel, has made significant strides in the field of pharmaceutical preparations. With a total of five patents to her name, Cohen continues to contribute to advancements in medical technology and treatment methodologies.
Latest Patents
Rakefet Cohen's recent innovative work primarily focuses on the "Process for Manufacturing Glatiramer Acetate Product." This patent outlines a comprehensive process for preparing a pharmaceutical formulation that includes glatiramer acetate and mannitol within a suitable container. The key features of this patent include the formulation of an aqueous pharmaceutical solution comprising 40 mg/ml of glatiramer acetate and 40 mg/ml of mannitol. Additionally, it describes the development of a prefilled syringe, an automated injector, and a method of treatment specifically tailored for human patients.
Career Highlights
Cohen's career is marked by her affiliation with Teva Pharmaceutical Industries Limited, where she has significantly influenced the production and formulation processes. Her expertise and inventive contributions have played a crucial role in enhancing pharmaceutical solutions and improving patient care.
Collaborations
Throughout her career, Rakefet Cohen has collaborated with notable individuals such as Michael Fox and Sasson Habbah. These partnerships not only highlight her ability to work within a team but also showcase the multidisciplinary approach often necessary for innovative developments in the pharmaceutical industry.
Conclusion
Rakefet Cohen's work exemplifies the spirit of innovation in the pharmaceutical sector. Her patents not only contribute to the advancement of medical preparations but also reflect her commitment to enhancing treatment options for patients. With her continued efforts at Teva Pharmaceutical Industries Limited, Cohen is set to remain at the forefront of pharmaceutical innovation.